Literature DB >> 3568338

The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.

J Stokes, W B Kannel, P A Wolf, L A Cupples, R B D'Agostino.   

Abstract

Substantial differences were noted in the risk profiles for various manifestations of cardiovascular disease (CVD) that occurred before the age of 65 during the first 30 years of follow-up of the 5070 subjects of the original Framingham cohort. Hypertension contributed most consistently to short-term risk of all manifestations of CVD. Differences were noted between the sexes and age groups in both the univariate and multivariate analyses. These patterns have biological, clinical, and statistical significance, particularly as they relate to the need for future studies to distinguish better between those factors that precipitate cardiovascular events and those that relate to the pathogenesis of the underlying atherosclerosis.

Entities:  

Mesh:

Year:  1987        PMID: 3568338

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

2.  Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities.

Authors:  Rachel P Wildman; Aileen P McGinn; Juan Lin; Dan Wang; Paul Muntner; Hillel W Cohen; Kristi Reynolds; Vivian Fonseca; MaryFran R Sowers
Journal:  Obesity (Silver Spring)       Date:  2010-08-19       Impact factor: 5.002

3.  The smoker's paradox and the real risk of smoking.

Authors:  Friedebert Kunz; Christoph Pechlaner; Helmut Hörtnagl; Rudolf Pfister
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  Treating hypertension in older adults: safety considerations.

Authors:  Wilbert S Aronow
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Greater collagen-induced platelet aggregation following cyclooxygenase 1 inhibition predicts incident acute coronary syndromes.

Authors:  Rehan Qayyum; Diane M Becker; Lisa R Yanek; Nauder Faraday; Dhananjay Vaidya; Rasika Mathias; Brian G Kral; Lewis C Becker
Journal:  Clin Transl Sci       Date:  2014-07-25       Impact factor: 4.689

Review 6.  The future of pharmacological therapy for risk factor reduction. Hypertension.

Authors:  L Hansson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 7.  Obesity and cardiovascular disease in women.

Authors:  Camila Manrique-Acevedo; Bhavana Chinnakotla; Jaume Padilla; Luis A Martinez-Lemus; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-17       Impact factor: 5.095

8.  Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.

Authors:  Eric Thorin; Mylan Pham-Dang; Robert Clement; Isabelle Mercier; Angelino Calderone
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

9.  Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.

Authors:  G Ranieri; V Filitti; A Andriani; M V Bonfantino; G Lamontanara; A Cavallo; M Milani; R De Cesaris
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

10.  Living healthier for longer: comparative effects of three heart-healthy behaviors on life expectancy with and without cardiovascular disease.

Authors:  Wilma J Nusselder; Oscar H Franco; Anna Peeters; Johan P Mackenbach
Journal:  BMC Public Health       Date:  2009-12-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.